Most of the huge groundswell for the two most common diabesity drugs — Eli Lilly’s tirzepatide and Novo Nordisk’s semaglutide — has been driven by
Read MoreTag: Lillys
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to
Read More